|
WO1998012332A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
|
DE69937419T2
(de)
|
1998-05-01 |
2008-07-24 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Neisseria Meningitidis Antigene und Zusammenstellungen
|
|
AU2109700A
(en)
|
1999-01-22 |
2000-08-07 |
Smithkline Beecham Biologicals (Sa) |
Novel compounds
|
|
ES2337650T3
(es)
|
1999-03-12 |
2010-04-28 |
Glaxosmithkline Biologicals S.A. |
Polipeptidos antigenicos de neisseria meningitidis polinucleotidos y anticuerpos protectores correspondientes.
|
|
US7368261B1
(en)
|
1999-04-30 |
2008-05-06 |
Novartis Vaccines And Diagnostics Srl |
Conserved Neisserial antigens
|
|
EP2270174A1
(en)
|
1999-05-19 |
2011-01-05 |
Novartis Vaccines and Diagnostics S.r.l. |
Combination neisserial compositions
|
|
PT2275554E
(pt)
|
1999-10-29 |
2015-06-26 |
Novartis Vaccines & Diagnostic |
Péptidos antigénicos de neisseria
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
EP2275129A3
(en)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
|
|
BR0107857A
(pt)
*
|
2000-01-25 |
2002-10-29 |
Univ Queensland |
Proteìnas compreendendo regiões conservadas de antìgeno nhha de superfìcie de neisseria meningitidis
|
|
PT1790660E
(pt)
|
2000-02-28 |
2012-09-17 |
Novartis Vaccines & Diagnostic |
Expressão heteróloga de proteínas de neisseria
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
KR20030024811A
(ko)
|
2000-07-27 |
2003-03-26 |
칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 |
나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
JP2004529643A
(ja)
*
|
2001-04-17 |
2004-09-30 |
カイロン コーポレイション |
機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物
|
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
|
CU23245A1
(es)
|
2001-07-16 |
2007-10-17 |
Inst De Medicina Tropical Pedr |
CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
EP1412381B1
(en)
|
2001-07-27 |
2010-06-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Antibodies against meningococcal adhesin app
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
US7807181B2
(en)
|
2002-03-20 |
2010-10-05 |
Emory University |
Neisseria mutants, lipooligosaccharides and immunogenic compositions
|
|
WO2004014417A2
(en)
*
|
2002-08-02 |
2004-02-19 |
Glaxosmithkline Biologicals Sa |
Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
SI2353608T1
(sl)
|
2002-10-11 |
2020-12-31 |
Glaxosmithkline Biologicals Sa |
Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
PT2172213E
(pt)
*
|
2003-01-30 |
2013-06-03 |
Novartis Ag |
Vacinas injetáveis contra múltiplos serogrupos meningocócicos
|
|
CU23237A1
(es)
|
2003-12-03 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
BRPI0607374B8
(pt)
|
2005-01-27 |
2021-05-25 |
Childrens Hospital & Res Center At Oakland |
vacinas de vesículas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
|
|
NZ599345A
(en)
|
2005-02-18 |
2013-07-26 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic Escherichia Coli
|
|
SI2351772T1
(sl)
|
2005-02-18 |
2016-11-30 |
Glaxosmithkline Biologicals Sa |
Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
|
|
US8119385B2
(en)
*
|
2005-03-04 |
2012-02-21 |
Bp Corporation North America Inc. |
Nucleic acids and proteins and methods for making and using them
|
|
CU23578A1
(es)
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
CU23549A1
(es)
*
|
2005-12-29 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Composiciones farmacéuticas que contienen la proteína nma0939
|
|
US8039007B2
(en)
|
2006-06-29 |
2011-10-18 |
J. Craig Venter Institute, Inc. |
Polypeptides from Neisseria meningitidis
|
|
JP2010500399A
(ja)
|
2006-08-16 |
2010-01-07 |
ノバルティス アーゲー |
尿路病原性大腸菌由来の免疫原
|
|
CU23630A1
(es)
|
2006-10-30 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
ES2532946T3
(es)
|
2008-02-21 |
2015-04-06 |
Novartis Ag |
Polipéptidos PUfH meningocócicos
|
|
SMT202000366T1
(it)
|
2009-03-24 |
2020-09-10 |
Glaxosmithkline Biologicals Sa |
Proteina legante fattore h di meningococco come adiuvante
|
|
AU2010247252A1
(en)
|
2009-05-14 |
2012-01-12 |
Sanofi Pasteur |
Method for admixing the lipopolysaccharide (LPS) of gram-negative bacteria
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
PL3246044T5
(pl)
|
2010-08-23 |
2024-06-17 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
|
US9259462B2
(en)
|
2010-09-10 |
2016-02-16 |
Glaxosmithkline Biologicals Sa |
Developments in meningococcal outer membrane vesicles
|
|
PE20140173A1
(es)
|
2010-09-10 |
2014-02-20 |
Wyeth Llc |
Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
EP4043029A1
(en)
|
2012-03-09 |
2022-08-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10376573B2
(en)
|
2012-06-14 |
2019-08-13 |
Glaxosmithkline Biologicals Sa |
Vaccines for serogroup X meningococcus
|
|
AU2013295242C1
(en)
|
2012-07-27 |
2018-08-09 |
Institut National De La Sante Et De La Recherche Medicale |
CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
EP3041502A2
(en)
|
2013-09-08 |
2016-07-13 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10888611B2
(en)
|
2015-02-19 |
2021-01-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
JP7010961B2
(ja)
|
2017-01-31 |
2022-02-10 |
ファイザー・インク |
髄膜炎菌組成物およびその方法
|
|
US12084704B2
(en)
*
|
2017-05-10 |
2024-09-10 |
Global Bioenergies |
Methods for producing isobutene from 3-methylcrotonic acid
|
|
BR112020001255A2
(pt)
|
2017-07-21 |
2020-07-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
composições imunogênicas de neisseria meningitidis
|
|
WO2020023717A2
(en)
*
|
2018-07-25 |
2020-01-30 |
The Trustees Of Indiana University |
Diagnostic assay for a strain of neisseria meningitidis
|
|
KR102871663B1
(ko)
|
2019-09-27 |
2025-10-16 |
화이자 인코포레이티드 |
네이세리아 메닌기티디스 조성물 및 그의 방법
|
|
CN113136444B
(zh)
*
|
2021-05-10 |
2024-04-19 |
临沂大学 |
医用食品中海氏肠球菌的微滴数字pcr检测方法
|
|
CN116162140B
(zh)
*
|
2022-07-19 |
2025-09-09 |
四川大学华西医院 |
一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|
|
WO2025077785A1
(zh)
*
|
2023-10-10 |
2025-04-17 |
康希诺生物股份公司 |
一种抗脑膜炎球菌的免疫组合物及其用途
|